Volker Schmieden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Volker Schmieden has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Dietmar Schmitz
Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Germany
1 shared publication Heinrich Betz
Department of Neurochemistry, Max-Planck Institute for Brain Research, Frankfurt/Main, Federal Republic of Germany
1 shared publicationJochen Kuhse
Department of Neurochemistry, Max-Planck Institute for Brain Research, Frankfurt/Main, Federal Republic of Germany
1 shared publicationJörg Breustedt
NeuroScience Research Center, Charité, Universitätsmedizin Berlin, Berlin, Germany
1 shared publicationUwe Heinemann
Johannes‐Müller‐Institute of Physiology, Charite, Universitätsmedizin Berlin, Tucholskystrasse 2, 10117 Berlin, Germany
1 shared publication
Latest Publications
- 8 April 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 19 (7) , 1987-1991
Characterization of the inhibitory glycine receptor on entorhinal cortex neurons
In addition to the well-established functional description of the glycine receptor (GlyR) in the spinal cord, GlyR expression has recently been found in higher brain regions, such as the striatum or hippocampus. In this study we have investigated the electrophysiological response of glycine in the rat entorhinal cortex slice. In all recorded cells we found significant current responses to glycine with an EC(50) value of about 100 micro m. Most importantly, we detected a cross-inhibition of glycine responses by GABA but not vice versa. These findings are in line with recent published data of cross-talks between GABA(A)R and GlyR but indicate a novel type of cross-inhibition of these receptors in the entorhinal cortex.
- 8 April 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 19 (7) , 1987-1991
Characterization of the inhibitory glycine receptor on entorhinal cortex neurons
In addition to the well-established functional description of the glycine receptor (GlyR) in the spinal cord, GlyR expression has recently been found in higher brain regions, such as the striatum or hippocampus. In this study we have investigated the electrophysiological response of glycine in the rat entorhinal cortex slice. In all recorded cells we found significant current responses to glycine with an EC(50) value of about 100 micro m. Most importantly, we detected a cross-inhibition of glycine responses by GABA but not vice versa. These findings are in line with recent published data of cross-talks between GABA(A)R and GlyR but indicate a novel type of cross-inhibition of these receptors in the entorhinal cortex.
- 1 September 1999
- Published by Elsevier in Molecular Pharmacology
- Vol. 56 (3) , 464-472
A Novel Domain of the Inhibitory Glycine Receptor Determining Antagonist Efficacies: Further Evidence for Partial Agonism Resulting from Self-Inhibition
Different amino side chains in the N-terminal extracellular region of the inhibitory glycine receptor (GlyR) have been shown to be crucial for ligand recognition. Here we describe a novel domain of the GlyRα1 subunit that constitutes an important determinant of antagonist activity. The antagonists strychnine, nipecotic acid, and isobutyric acid displayed reduced potencies at recombinant GlyRs formed from α1 subunits, in which lysine 104, phenylalanine 108, or threonine 112 were replaced by alanine. Agonist affinities, in contrast, were slightly increased at these mutant receptors. Taurine and β-aminoisobutyric acid, which are partial agonists at the wild-type GlyR, behaved as full agonists at the mutant GlyRs and failed to inhibit glycine-induced currents. This is consistent with apolar residues at positions 104, 108, and 112 of the α1 subunit reducing the antagonistic, but not the agonistic, binding of β-amino acids. Our data support a model in which the partial agonism of β-amino acids results from their self-inhibitory activity.
- 1 September 1999
- Published by Elsevier in Molecular Pharmacology
- Vol. 56 (3) , 464-472
A Novel Domain of the Inhibitory Glycine Receptor Determining Antagonist Efficacies: Further Evidence for Partial Agonism Resulting from Self-Inhibition
Different amino side chains in the N-terminal extracellular region of the inhibitory glycine receptor (GlyR) have been shown to be crucial for ligand recognition. Here we describe a novel domain of the GlyRα1 subunit that constitutes an important determinant of antagonist activity. The antagonists strychnine, nipecotic acid, and isobutyric acid displayed reduced potencies at recombinant GlyRs formed from α1 subunits, in which lysine 104, phenylalanine 108, or threonine 112 were replaced by alanine. Agonist affinities, in contrast, were slightly increased at these mutant receptors. Taurine and β-aminoisobutyric acid, which are partial agonists at the wild-type GlyR, behaved as full agonists at the mutant GlyRs and failed to inhibit glycine-induced currents. This is consistent with apolar residues at positions 104, 108, and 112 of the α1 subunit reducing the antagonistic, but not the agonistic, binding of β-amino acids. Our data support a model in which the partial agonism of β-amino acids results from their self-inhibitory activity.